Differential steroid hormone and neural influences on peptide mRNA levels in CRH cells of the paraventricular nucleus: A hybridization histochemical study in the rat

Journal of Comparative Neurology

Volumn 285, Issue 4, 1989, Pages 413-435

  Swanson, L W ^a   Simmons, D M ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

angiotensin; cholecystokinin; corticotropin releasing hormone; enkephalin; glucocorticoid receptor; in situ hybridization; mineralocorticoid receptor; vasopressin

Indexed keywords

ANGIOTENSIN; CHOLECYSTOKININ; CORTICOSTEROID; CORTICOSTERONE; CORTICOTROPIN; ENKEPHALIN; MESSENGER RNA; STEROID RECEPTOR; VASOPRESSIN;

AGED; ANIMAL CELL; GENETIC ENGINEERING; HISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PARAVENTRICULAR NUCLEUS; PRIORITY JOURNAL; RAT;

ADRENALECTOMY; ANIMAL; AUTORADIOGRAPHY; CORTICOSTERONE; CORTICOTROPIN-RELEASING HORMONE; KINETICS; MALE; NEURONS; NEUROPEPTIDES; NUCLEIC ACID HYBRIDIZATION; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RATS, INBRED STRAINS; RECEPTORS, GLUCOCORTICOID; REFERENCE VALUES; RNA, MESSENGER; SULFUR RADIOISOTOPES; SUPPORT, U.S. GOV'T, P.H.S.; TYROSINE 3-MONOOXYGENASE;

EID: 0024332335     PISSN: 00219967     EISSN: 10969861     Source Type: Journal    
DOI: 10.1002/cne.902850402     Document Type: Article

References (135)

1. Estimation of nuclear population from microtome sections
2. Morphometrical analysis of the distribution of corticotrophin releasing factor, glucocorticoid receptor and phenylethanolamine‐N‐methyltransferaseimmunoreactive structures in the paraventricular hypothalamic nucleus of the rat
3. Constant corticosterone replacement normalizes basal adrenocorticotropin (ACTH) but permits sustained ACTH hypersecretion after stress in adrenalectomized rats
4. Negative regulation by glucocorticoids through interference with a cAMP responsive enhancer
5. Immunoreactivity of hypothalamoneurohypophysial neurons which secrete corticotropin‐releasing hormone (CRH) and vasopressin (Vp): Immunocytochemical evidence for a correlation with their functional state in colchicine‐treated rats
6. In situ hybridization with RNA probes: An annotated recipe
7. Immunoreactive corticotropin‐releasing hormone in the hypothalamoinfundibular tract
8. Hypothalamo‐neurohypophyseal neurosecretion after extirpation of various endocrine glands
9. Cloning of human mineralocorticoid receptor complementary DNA: Structural and functional kinship with the glucocorticoid receptor
10. The neuronal mineralocorticoid receptor as a mediator of glucocorticoid response
11. Glucocorticoid regulation of vasopressin messenger RNA
12. Influence of various corticoids on the augmentation of ‘Gomoripositive’ granules in the median eminence of the rat following adrenalectomy. Naunyn Schmiedebergs Arch
13. Changes in corticoliberin and vasopressin‐like immunoreactivities in the zona externa of the median eminence in adrenalectomized rats. Immunocytochemical study
14. Infundibular localization of vasopressin, oxytocin, and neurophysins in the rat; Its relationships with corticotrope function
15. Immunohistochemistry of vasopressin: Study of the hypothalamo‐neurohypophysial system of normal, dehydrated and hypophysectomized rats
16. Comparative immunocytochemical localization of corticotropin releasing factor (CRF‐41) and neurohypophyseal peptides in the brain of Brattleboro and Long‐Evans rats
17. The vasopressin mRNA poly(A) tract is unusually long and increases during stimulation of vasopressin gene expression in vivo
18. Distribution of tyrosine‐hydroxylase immunoreactive neurons in the hypothalamus of rats
19. Presence of glucocorticoid receptor immunoreactivity in corticotrophin releasing factor and in growth hormone releasing factor immunoreactive neurons of the rat di‐ and telencephalon
20. Regulation of ACTH secretion: Variations on a theme of B
21. Cerebral involvement in the inhibition of ACTH secretion in hydrocortisone
22. Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleus of the rat
23. Feedback action and tonic influence of corticosteroids on brain function: A concept arising from the heterogeneity of brain receptor systems
24. A gene encoding rat cholecystokinin
25. Modulation of corticotrophin‐releasing factor release from hypothalamic synaptosomes
26. Hormonal “feed‐back” regulation of pituitary‐adrenocortical activity
27. The Hypothalamic‐Pituitary‐Adrenal Axis Revisited
28. An anterograde neuroanatomical tracing method that shows the detailed morphology of neurons, their axons and terminals: Immunohistochemical localization of an axonally transported plant lectin, Phaseolus vulgaris leucoagglutinin (PHA‐L)
29. Corticotropin‐releasing hormone and its vasopressin component
30. Variations in concentration of oxytocin and vasopressin in the paraventricular nucleus of the hypothalamus during the estrous cycle in rats
31. Complete coding sequence of rat tyrosine hydroxylase mRNA
32. Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization
33. Angiotensinogen gene expression in extrahepatic rat tissues: Application of a solution hybridization assay
34. Effect of bilateral adrenalectomy and corticosteroid therapy on the secretion of corticotrophin‐releasing factor from the hypothalamus of the rat in vitro
35. The PHI (PHI‐27)/corticotropin‐releasing factor/enkephalin immunoreactive hypothalamic neuron: Possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion
36. Primary structure and expression of a functional human glucocorticoid receptor cDNA
37. Predominant release of vasopressin vs. corticotropin‐releasing factor from the isolated median eminence after adrenalectomy
38. Effect of chronic stress on the level of corticotropin‐releasing factor (CRF) mRNA in rat brain
39. Suppression by glucocorticoid of the immunoreactivity of corticotropin‐releasing factor and vasopressin in the paraventricular nucleus of rat hypothalamus
40. Effects of adrenalectomy and dexamethasone administration on the level of prepro‐corticotropin‐releasing factor messenger ribonucleic acid (mRNA) in the hypothalamus and adrenocorticotropin/b‐lipotropin precursor mRNA in the pituitary in rats
41. Cloning and sequence analysis of cDNA for rat corticotropin‐releasing factor precursor
42. Influence of substance P on hypothalamo‐pituitary‐adrenocortical activity in the rat
43. Dynamics and mechanics of corticosteroid feedback at the hypothalamus and anterior pituitary gland
44. Influence of ascending noradrenergic fibers on the neurotensin‐like immunoreactive neurons in the rat paraventricular nucleus
45. Functional topography of the rat hypothalamic dopamine neuron systems: Retrograde tracing and immunohistochemical study
46. Tyrosine hydroxylase in magnocellular neurosecretory neurons
47. Corticotropin‐releasing factor‐immunoreactive neurons of the paraventricular nucleus become vasopressin positive after adrenalectomy
48. Glucocorticoid receptor in magnocellular neurosecretory cells
49. Distribution and projections of cholecystokinin‐immunoreactive neurons in the hypothalamic paraventricular nucleus of rat
50. Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotropin‐releasing factor and arginine vasopressin immunostaining induced by adrenalectomy
51. Dexamethasone inhibits corticotropin‐releasing factor gene expression in the rat paraventricular nucleus
52. Three rat preprotachykinin mRNAs encode the neuropeptides substance P and neurokinin A
53. Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line
54. Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal
55. Vasopressin, oxytocin, dynorphin, enkephalin and corticotrophin‐releasing factor mRNA stimulation in the rat
56. Corticotrophin‐releasing factor, vasopressin and pro‐opiomelanocortin mRNA responses to stress and opiates in the rat
57. The distribution of angiotensin II‐immunoreactive cells and fibers in the paraventriculo‐hypophysial system of the rat
58. Anatomical evidence that neural circuits related to the subfornical organ contain angiotensin II
59. Ultrastructural alterations of the paraventriculo‐infundibular corticotropin releasing factor (CRF)‐immunoreactive neuronal system in long term adrenaletomized rats
60. Distribution of substance P‐like immunoreactivity in the central nervous system of the rat. I. Cell bodies and nerve terminals
61. Measurement of mRNA by solution hybridization with 32P‐labelled single stranded cRNA probe (‘SP6 test’). Comparison with a 32P‐labelled single stranded cDNA as hybridization probe (‘S1 test’) for measurement of AVP mRNA
62. Localization of brain angiotensinogen mRNA by hybridization histochemistry
63. Posttranslational processing of α‐, β‐, and γ‐preprotachykinins. Cell‐free translation and early posttranslational processing events
64. A substance P‐containing hypothalamic neuronal system projects to the median eminence
65. Studies on the loci of action of cortical hormones in inhibiting the release of adrenocorticotrophin
66. The paraventriculo‐infundibular corticotropin releasing factor (CRF) pathway as revealed by immunocytochemistry in long‐term hypophysectomized or adrenalectomized rats
67. Increase of corticotropin‐releasing factor staining in rat paraventricular nucleus neurones by depletion of hypothalamic adrenaline
68. Role of cholecystokinin in corticotropin release: Coexistence with vasopressin and corticotropin‐releasing factor in cells of the rat hypothalamic paraventricular nucleus
69. Distribution of cholecystokinin‐immunoreactive cell bodies in the male and female rat: I. Hypothalamus
70. Genetic complementation of a glucocorticoid receptor deficiency by expression of cloned receptor cDNA
71. The efferent projections of the subfornical organ of the rat: A circumventricular organ within a neural network subserving water balance
72. Glucocorticoids enhance stability of human growth hormone mRNA
73. Comparative distribution of bombesin/GRP‐ and substance‐P‐like immunoreactivities in rat hypothalamus
74. A new hypothalamic pathway to the median eminence containing neurophysin and its hypertrophy in sheep with natural scrapie
75. The corticotropin releasing factor (CRF) neurosecretory system in intact, adrenalectomized, and adrenalectomized‐dexamethasone treated rats
76. Hypophysial‐portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin‐releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy
77. Effect of plasma from hypophyseal‐portal vessel blood on adrenal ascorbic acid
78. 3H‐dexamethasone in the rat brain and pituitary
79. Two receptor systems for corticosterone in rat brain: Microdistribution and differential occupation
80. Estrogen‐concentrating, neurophysin‐containing hypothalamic neurons in the vasopressin‐deficient (Brattleboro) rat: A study combining steroid autoradiography and immunocytochemistry
81. In vivo corticotropin‐releasing factor‐induced secretion of adrenocortiotropin, β‐endorphin, and corticosterone
82. Diminished responsiveness of the hypothalamic‐pituitary‐adrenal axis of the rat during exposure to prolonged stress: A pituitary‐mediated mechanism
83. Quantitation of changes in the content of neurohypophyseal peptides in hypothalamic nuclei after adrenalectomy
84. Changes in the rat neurohypophysis induced by painful stimuli with particular reference to neurosecretory material
85. 3H estradiol and neurophysin I or agrinine vasopressin in hypothalamic neurons using a combined technique of dry mount autoradiography and immunohistochemistry
86. Corticosterone‐induced changes in hypothalamic corticotropin‐releasing factor (CRF) content after stress
87. Adrenalectomy‐induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: Autonomic, peptide, and steroid specificity
88. Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus
89. Evidence for differential regulation of corticotropin‐releasing factor and vasopressin immunoreactivities in parvocellular neurosecretory and autonomic‐related projections of the paraventricular nucleus
90. The effects of catecholamine‐depleting medullary knife cuts of CRF‐ and vasopressin‐immunoreactivity in the hypothalamus of normal and steroid‐manipulated rats
91. Immunohistochemical identification of neurons in the paraventricular nucleus of the hypothalamus that project to the medulla or to the spinal cord in the rat
92. Adrenalectomy‐induced enhancement of CRF‐ and vasopressin‐immunoreactivity in parvocellular neurosecretory neurons: Anatomic, peptide, and steroid specificity
93. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular and supraoptic nuclei in the rat
94. Corticotropin‐releasing factor: Coexpression within distinct subsets of oxytocin‐, vasopressin‐, and neurotensin‐immunoreactive neurons in the hypothalamus of the male rat
95. Co‐expression of corticotropin‐releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat
96. Gene expression of neuropeptides related to CRF after adrenalectomy
97. Coordinate expression of hypothalamic pro‐dynorphin and pro‐vasopressin mRNAs with osmotic stimulation
98. Opioid peptides and vasopressin: The application of in situ hybridization to studies of the hypothalamus and pituitary
99. Adrenal steroid inhibition of the vasopressin‐neurophysin neurosecretory system to the median eminence of the rat
100. The effect of a CRF preparation on ACTH release in rats bearing hypothalamic dexamethasone implants: A study on the “implantation paradox
101. Effects of implantation of cortisol into the brain stem or pituitary gland on the adrenal response to stress in the rabbit
102. The effects of adrenalectomy and glucocorticoid replacement on vasopressin and vasopressin‐neurophysin in the zona externa of the median eminence of the rat
103. Recherches expérimentales sur le complexe hypothalamo‐hypophysaire
104. Effects of bilateral adrenalectomy on immunoreactive corticotropin‐releasing factor in the rat median eminence and intermediate‐posterior pituitary
105. Effect of dexamethasone on immunoreactive corticotropin‐releasing factor in the rat median eminence and intermediate‐posterior pituitary
106. Neuropeptides. New vistas on synaptic transmission
107. The paraventricular nucleus of the hypothalamus: Cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double‐labeling methods
108. An immunohistochemical study of the organization of catecholaminergic cells and terminal fields in the paraventricular and supraoptic nuclei of the hypothalamus
109. Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: Implications for the stress response
110. The CRH motoneuron: Differential peptide regulation in neurons with possible synaptic, paracrine, and endocrine outputs
111. Organization of ovine corticotropin‐releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study
112. Rat corticotropin‐releasing hormone gene: Sequence and tissue‐specific expression
113. Immunohistochemical localization of CRF‐containing nerve terminals in the median eminence of guinea pig and rat
114. Ability of the CRF immunoreactive neurons of the paraventricular nucleus to produce a vasopressin‐like material
115. Characterization of a 41‐residue ovine hypothalamic peptide that stimulates the secretion of corticotropin and β‐endorphin
116. Tyrosine hydroxylase‐immunoreactive neurons of the hypothalamus: A light and electron microscopic study
117. The origin of the vasopressinergic and oxytocinergic fibres of the external region of the median eminence of the rat hypophysis
118. A superfusion system technique for the study of the sites of action of glucocorticoids in the rat hypothalamus‐pituitary‐adrenal system in vito. II. Hypothalamus‐pituitary cell‐adrenal cell superfusion
119. Pituitary‐adrenal function in rats chronically exposed to cold
120. Effect of stress, adrenalectomy, hypophysectomy and hydrocortisone on the corticotropin‐releasing activity of rat median eminence
121. Vasopressin‐containing and vasopressin‐deficient subpopulations of corticotropin‐releasing factor axons are differentially affected by adrenalectomy
122. Co‐localization of corticotropin‐releasing factor and vasopressin in median eminence neurosecretory vesicles
123. Vasopressin coexists in half of the corticotropin‐releasing factor axons present in the external zone of the median eminence in normal rats
124. Co‐localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy
125. Stimulation and inhibition of adrenocorticotropin release
126. Rat brain preproenkephalin mRNA
127. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin‐releasing factor mRNA after adrenalectomy in rats
128. Vasopressin and oxytocin mRNAs in adrenalectomized and Brattleboro rats: Analysis by quantitative in situ hybridization histochemistry
129. Tyrosine hydroxylase mRNA is increased by hyperosmotic stimuli in the paraventricular and supraoptic nuclei